6 IPOs on Tap for This Week
Renaissance Capital IPO Research submits:
The following IPOs are expected to price this week: Aegerion Pharmaceuticals (AEGR), which is developing a drug for an orphan disease that produces fatal levels of cholesterol, plans to raise $70 million by offering 4.7 million shares at a price range of $14-$16. At the mid-point of the proposed range, Aegerion Pharmaceuticals will command a market value of $232 million. Aegerion Pharmaceuticals, which was founded in 2005, has yet to generate product revenue. The Bridgewater, NJ-based company plans to list on the NASDAQ under the symbol AEGR. Leerink Swann and Lazard Capital Markets (LAZ) are the lead underwriters on the deal. Complete Story »
- Original article
- Login or register to post comments

